The pneumonia market is witnessing significant growth due to the rising cases of HIV/AIDS and cancer, which compromise immune systems and increase susceptibility to infections.

1. Pneumonia
Market Research
Report 2023-
2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Pneumonia Market 2023-2033
The newly published report by IMARC Group, titled ”Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and
Forecast 2023-2033″, presents a comprehensive analysis of the pneumonia market. The report provides an overview of the market trends,
growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth
trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The
report also highlights key segments and market drivers, as well as challenges faced by industry players.
Pneumonia Market:
The 7 major pneumonia markets are expected to exhibit a CAGR of 5.6% during 2023-2033.
Request a Sample Report: https://www.imarcgroup.com/pneumonia-market/requestsample
3

4. Report Description and Highlights
What is pneumonia?
Pneumonia, an infection triggering inflammation and fluid accumulation in the lungs’ air sacs, can vary in severity and affect all age groups
but is particularly risky for older adults, infants, and immunocompromised individuals. Typical symptoms comprise a productive cough,
fever, chills, labored breathing, chest pain, nausea, vomiting, loss of appetite, tiredness, and confusion. More severe cases may also exhibit
an elevated heart rate, body aches, and cyanosis of the lips or nails. Diagnosing pneumonia involves a blend of patient history, physical
examination, and multiple diagnostic procedures. Clinicians often listen to the lungs for unusual sounds, like crackles or wheezes, with a
stethoscope. A chest X-ray is routinely employed to detect inflammation or fluid in the lungs, while tests like sputum culture, pulse
oximetry, and blood tests further aid in verifying the diagnosis.
What are the key drivers and trends in the Pneumonia market?
The pneumonia market is witnessing significant growth due to the rising cases of HIV/AIDS and cancer, which compromise immune systems
and increase susceptibility to infections. Besides, an upsurge in hazardous chemical exposure and smoking, which impair lung functions
and impede the clearance of harmful bacteria and substances, is fueling the market’s positive trajectory.
4

5. Report Description and Highlights
The wide acceptance of potent antibiotics, such as macrolides, penicillin, and cephalosporins, used to bolster immune responses and
alleviate symptoms in patients, is also spurring market expansion. Moreover, the rise in chest physiotherapy techniques like percussion,
vibration, and postural drainage that aid in mobilizing lung mucus is contributing to the growth. Lastly, the emerging preference for
nebulized medications due to their superior benefits, including enhanced drug distribution and absorption and faster action compared to
oral therapies, is anticipated to further propel the pneumonia market in the forecasted period.
5

6. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
6

7. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Pneumonia market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Pneumonia market
• Reimbursement scenario in the market
• In-market and pipeline drugs
7

8. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/pneumonia-market
8

9. Key Questions Answered in the Report
1. How has the Pneumonia Market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Pneumonia Market across the seven major markets in 2022 and what will it look like in 2033?
4. What is the growth rate of the Pneumonia Market across the seven major markets and what will be the expected growth over the next
ten years?
5. What are the key unmet needs in the market?
9

10. Table of
Contents

11. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
11

12. Table of Contents
4 Pneumonia - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Pneumonia - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/pneumonia-market/toc
12

13. Partial List Of Our Clients
13

14. OUR CLIENTS
14

15. Disclaimer
15
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.